Dare Bioscience, Inc. financial data

Symbol
DARE on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 74% % -23%
Debt-to-equity -432% % 29%
Return On Equity 274% % 183%
Return On Assets -83% % -336%
Operating Margin -1235% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14,289,229 shares 64%
Common Stock, Shares, Outstanding 13,929,502 shares 63%
Entity Public Float $33,967,214 USD -56%
Common Stock, Value, Issued $1,393 USD 63%
Weighted Average Number of Shares Outstanding, Basic 12,755,112 shares 49%
Weighted Average Number of Shares Outstanding, Diluted 12,755,112 shares 49%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $1,881,316 USD -96%
Revenue from Contract with Customer, Excluding Assessed Tax $2,262 USD -95%
Research and Development Expense $8,137,453 USD -45%
General and Administrative Expense $9,182,354 USD -11%
Operating Income (Loss) $17,469,263 USD 25%
Net Income (Loss) Attributable to Parent $17,463,954 USD -384%
Earnings Per Share, Basic -1 USD/shares -19%
Earnings Per Share, Diluted -1 USD/shares -18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $23,075,261 USD 105%
Other Assets, Current $53,159 USD
Assets, Current $25,004,180 USD 67%
Property, Plant and Equipment, Net $1,657,255 USD 135%
Operating Lease, Right-of-Use Asset $824,693 USD -38%
Other Assets, Noncurrent $1,018,373 USD 91%
Assets $30,748,574 USD 70%
Accounts Payable, Current $1,844,862 USD 76%
Employee-related Liabilities, Current $805,612 USD 0.02%
Accrued Liabilities, Current $2,324,931 USD 26%
Liabilities, Current $21,216,394 USD 61%
Contract with Customer, Liability, Noncurrent $1,000,000 USD 0%
Operating Lease, Liability, Noncurrent $288,566 USD -68%
Liabilities $27,890,671 USD 43%
Accumulated Other Comprehensive Income (Loss), Net of Tax $395,966 USD -9.2%
Retained Earnings (Accumulated Deficit) $187,247,186 USD -10%
Stockholders' Equity Attributable to Parent $2,857,903 USD
Liabilities and Equity $30,748,574 USD 70%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,470,543 USD 20%
Net Cash Provided by (Used in) Financing Activities $246,577 USD 1657%
Net Cash Provided by (Used in) Investing Activities $157,331 USD -2056%
Common Stock, Shares Authorized 240,000,000 shares 0%
Common Stock, Shares, Issued 13,929,502 shares 63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,368,207 USD 22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $23,375,261 USD 103%
Deferred Tax Assets, Valuation Allowance $114,668,000 USD 2.1%
Deferred Tax Assets, Gross $114,668,000 USD 2.1%
Operating Lease, Liability $898,000 USD -36%
Depreciation $10,778 USD 13%
Payments to Acquire Property, Plant, and Equipment $157,331 USD 2056%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $17,497,295 USD -393%
Lessee, Operating Lease, Liability, to be Paid $976,000 USD -39%
Property, Plant and Equipment, Gross $1,511,626 USD 89%
Operating Lease, Liability, Current $609,224 USD 20%
Lessee, Operating Lease, Liability, to be Paid, Year Two $130,000 USD -81%
Lessee, Operating Lease, Liability, to be Paid, Year One $680,000 USD 3%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $78,000 USD -62%
Lessee, Operating Lease, Liability, to be Paid, Year Three $130,000 USD -75%
Deferred Tax Assets, Operating Loss Carryforwards $86,589,000 USD 0.47%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $2,824,000 USD 7.9%
Operating Lease, Payments $614,700 USD 9.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $158,110 USD 1367%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%